[
  {
    "uuid": "d222ab418f800a6bfa95d492f719f13e76e02f5d",
    "url": "https://uk.finance.yahoo.com/news/ensysce-biosciences-stock-doubles-one-211143048.html",
    "ord_in_thread": 0,
    "author": "Vandana Singh",
    "published": "2025-04-23T21:11:00Z",
    "title": "Ensysce Biosciences Stock Doubles In One Trading Session - Here's Why",
    "text": "trump tariffs live White House considers slashing China tariffs Ensysce Biosciences Stock Doubles In One Trading Session - Here's Why Vandana Singh Thu, 24 Apr 2025, 0:11 am 3 min read In this article: ENSCW 0.00% Ensysce Biosciences Stock Doubles In One Trading Session - Here's Why Ensysce Biosciences, Inc (NASDAQ: ENSC ) stock gained almost 100% with a strong session volume compared to the average volume of 81.23K, as per data from Benzinga Pro .\nEnsysce Biosciences on Wednesday received a Notice of Allowance from the U.S. Patent and Trademark Office for the issuance of a patent entitled Enzyme-Cleavable Methadone Prodrugs and Methods of Use Thereof including both composition of matter and method of use claims .\nPF9001, the medication covered by this patent, is designed to provide a safer treatment option for opioid use disorder (OUD) by using Ensysceâ€™s TAAP and MPAR abuse-deterrent and overdose protection technologies .\nAlso Read: Why Is Summit Therapeutics Stock Soaring On Wednesday?\nMethadone has long been used for OUD, but concerns over cardiac side effects, respiratory depression, and risk of overdose have limited its use.\nEnsysce has developed a new class of agents for OUD in the form of PF9001.\nData demonstrating a reduction in the potential for cardiotoxicity, validating MPAR overdose protection, and indications of potentially delivering a prolonged and predictable effect following once-daily dosing.\nThe National Institute on Drug Abuse of the National Institutes of Health supported the research covered by this patent.\nEnsysce Biosciences completed Part 1 of its second clinical trial in April to evaluate PF614-MPAR for overdose protection .\nPF614-MPAR-102 demonstrated that the combined Ensysce TAAP and MPAR technologies can relieve severe pain yet protect from the risk of excessive doses when consumed accidentally or deliberately.\nPart 1 of this second study of PF614-MPAR overdose protection confirmed that a 100 mg dosage of PF614-MPAR delivers oxycodone to treat severe pain and provides overdose protection when a greater-than-prescribed dose is consumed.\nThe data showed that the maximum amount of oxycodone released from PF614-MPAR, when three or more doses were taken at one time (Cmax), was reduced compared to that released following the consumption of the same amount of PF614 alone, evidence of overdose protection.\nWhen five doses of PF614-MPAR were administered, overdose protection was appropriately greater than that observed from three dose units.\nAdditionally, safety data from the trial showed no unexpected adverse events from either PF614 or PF614-MPAR.\nThe trial will now continue to enroll Part 2 to examine potential food effects and Part 3 to evaluate repeat dosing of PF614 vs. PF614-MPAR. The aggregate data will allow the company to focus on perfecting a final drug product to move into commercialization.\nStory continues Ensysce Biosciences announced approximately $1.1 million of registered direct offering in March by issuing 315,188 shares at $3.49 per share .\nPrice Action: ENSC stock is up 96.30% at $3.67 on Wednesday.\nRead Next:\nRezolute â€˜Thrilledâ€™ With Positive Review Of Genetic Disorder Trial, Expects Topline Results In December\nPhoto by Gorodenkoff via Shutterstock\nUp Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market.\nGet the latest stock analysis from Benzinga?\nThis article Ensysce Biosciences Stock Doubles In One Trading Session - Here's Why originally appeared on Benzinga.com\nÂ© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.\nTerms and Privacy Policy Privacy & Cookie Settings Recommended stories",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "positive",
    "categories": [
      "Economy, Business and Finance",
      "Health"
    ],
    "topics": [
      "Economy, Business and Finance->investment and opinion pieces",
      "Economy, Business and Finance->business reporting and performance",
      "Economy, Business and Finance->financial and economic news",
      "Health->health organisation"
    ],
    "ai_allow": true,
    "has_canonical": false,
    "breaking": true,
    "webz_reporter": false,
    "external_links": [
      "https://www.benzinga.com/pro/feature/newsfeed?utm_campaign=partner_feed&utm_source=yahooFinance&utm_medium=partner_feed&utm_content=site&nid=44966908",
      "https://www.benzinga.com/general/health-care?utm_campaign=partner_feed&utm_source=yahooFinance&utm_medium=partner_feed&utm_content=site&nid=44966908",
      "https://www.benzinga.com",
      "https://www.benzinga.com/general/biotech/25/04/44963467/why-is-summit-therapeutics-stock-soaring-on-wednesday?utm_campaign=partner_feed&utm_source=yahooFinance&utm_medium=partner_feed&utm_content=site&nid=44966908",
      "http://www.benzinga.com/",
      "https://s.yimg.com/ny/api/res/1.2/EIJEKhvKRUMCKhtvTWFinA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTE5NDtoPTQ4/https://s.yimg.com/os/creatr-uploaded-images/2020-11/f4b4e310-2b77-11eb-afee-ca1478f0e9ef",
      "https://www.benzinga.com/pressreleases/25/04/ac44810577/ensysce-biosciences-announces-positive-data-from-opioid-overdose-protection-study?utm_campaign=partner_feed&utm_source=yahooFinance&utm_medium=partner_feed&utm_content=site&nid=44966908",
      "https://www.benzinga.com/general/biotech/25/04/44963523/rezolute-thrilled-with-positive-review-of-genetic-disorder-trial-expects-topline-results-in-december?utm_campaign=partner_feed&utm_source=yahooFinance&utm_medium=partner_feed&utm_content=site&nid=44966908",
      "https://www.benzinga.com/25/04/44966908/ensysce-biosciences-stock-soars-on-us-patent-win-for-methadone-alternative-for-opioid-overdose-protective",
      "https://www.benzinga.com/pressreleases/25/03/ac44559449/ensysce-biosciences-inc-announces-1-1-million-registered-direct-offering-priced-at-the-market-und?utm_campaign=partner_feed&utm_source=yahooFinance&utm_medium=partner_feed&utm_content=site&nid=44966908",
      "https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9spja3yaad1&utm_source=yahoo",
      "https://www.benzinga.com/pressreleases/25/04/ac44946545/ensysce-biosciences-receives-u-s-patent-for-groundbreaking-treatment-of-opioid-use-disorder?utm_campaign=partner_feed&utm_source=yahooFinance&utm_medium=partner_feed&utm_content=site&nid=44966908",
      "https://www.benzinga.com/pressreleases/25/04/ac44810577/ensysce-biosciences-announces-positive-data-from-opioid-overdose-protection-study",
      "https://benzinga.com/pressreleases/25/03/ac44559449/ensysce-biosciences-inc-announces-1-1-million-registered-direct-offering-priced-at-the-market-und?utm_campaign=partner_feed&utm_source=yahooFinance&utm_medium=partner_feed&utm_content=site&nid=44966908",
      "https://benzinga.com/pressreleases/25/04/ac44810577/ensysce-biosciences-announces-positive-data-from-opioid-overdose-protection-study?utm_campaign=partner_feed&utm_source=yahooFinance&utm_medium=partner_feed&utm_content=site&nid=44966908",
      "https://benzinga.com/pressreleases/25/04/ac44946545/ensysce-biosciences-receives-u-s-patent-for-groundbreaking-treatment-of-opioid-use-disorder?utm_campaign=partner_feed&utm_source=yahooFinance&utm_medium=partner_feed&utm_content=site&nid=44966908",
      "https://benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9spja3yaad1&utm_source=yahoo",
      "https://www.benzinga.com/pro/feature/newsfeed",
      "https://www.benzinga.com/general/biotech/25/04/44963523/rezolute-thrilled-with-positive-review-of-genetic-disorder-trial-expects-topline-results-in-december",
      "https://benzinga.com/general/biotech/25/04/44963467/why-is-summit-therapeutics-stock-soaring-on-wednesday?utm_campaign=partner_feed&utm_source=yahooFinance&utm_medium=partner_feed&utm_content=site&nid=44966908",
      "http://benzinga.com/",
      "https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/",
      "https://www.benzinga.com/pressreleases/25/04/ac44946545/ensysce-biosciences-receives-u-s-patent-for-groundbreaking-treatment-of-opioid-use-disorder",
      "https://www.benzinga.com/general/health-care",
      "https://benzinga.com/25/04/44966908/ensysce-biosciences-stock-soars-on-us-patent-win-for-methadone-alternative-for-opioid-overdose-protective",
      "https://benzinga.com/general/biotech/25/04/44963523/rezolute-thrilled-with-positive-review-of-genetic-disorder-trial-expects-topline-results-in-december?utm_campaign=partner_feed&utm_source=yahooFinance&utm_medium=partner_feed&utm_content=site&nid=44966908",
      "https://benzinga.com/pro/feature/newsfeed?utm_campaign=partner_feed&utm_source=yahooFinance&utm_medium=partner_feed&utm_content=site&nid=44966908",
      "https://www.benzinga.com/pressreleases/25/03/ac44559449/ensysce-biosciences-inc-announces-1-1-million-registered-direct-offering-priced-at-the-market-und",
      "http://www.benzinga.com",
      "https://benzinga.com/general/health-care?utm_campaign=partner_feed&utm_source=yahooFinance&utm_medium=partner_feed&utm_content=site&nid=44966908",
      "https://www.s.yimg.com/ny/api/res/1.2/EIJEKhvKRUMCKhtvTWFinA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTE5NDtoPTQ4/https://www.s.yimg.com/os/creatr-uploaded-images/2020-11/f4b4e310-2b77-11eb-afee-ca1478f0e9ef",
      "https://benzinga.com",
      "https://www.benzinga.com/general/biotech/25/04/44963467/why-is-summit-therapeutics-stock-soaring-on-wednesday"
    ],
    "entities": {
      "persons": [
        {
          "name": "Vandana Singh Thu",
          "sentiment": "none"
        }
      ],
      "locations": [
        {
          "name": "White House",
          "sentiment": "none"
        }
      ],
      "organizations": []
    },
    "syndication": {
      "syndicated": false,
      "syndicate_id": null,
      "first_syndicated": false
    },
    "trust": {
      "categories": [],
      "bias": "center",
      "source": {
        "type": null,
        "city": null,
        "state": null,
        "country": null,
        "domain_type": null,
        "agency": null,
        "organization_name": null
      }
    },
    "rating": null,
    "crawled": "2025-04-24T00:41:05.248+03:00",
    "updated": "2025-04-24T00:41:05.248+03:00"
  },
  {
    "uuid": "96d51d67d9baa7676e691d7a05ba632c9f695414",
    "url": "https://www.fox4news.com/news/apple-products-iphone-ipod-macintosh-computer-marketing",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "Chris Williams",
    "published": "2025-02-27T22:02:00Z",
    "title": "How Apple's iconic products reshaped everyday life: A look back at decades of innovation | FOX 4 Dallas-Fort Worth",
    "text": "Full episode: Apple's biggest product releases through the years Appleâ€™s marketing machine is almost as effective as its skilled engineers. In this LiveNOW & Then episode, we look back at how the media has covered the tech company, from its IPO in 1980 to its iconic status today.\nApple products have reached a certain stratosphere among consumers, a level that&apos;s enviable and somewhat unattainable by other technology firms.\nWhen Apple pushes a product, consumers immediately flock to stores to grab it â€“ so much so that crowds attract media attention. It&apos;s not only because of their design, but how Apple products have seemingly revolutionized everyday life.\nTimeline:\nHere&apos;s a look at the list of Apple products through the decades and how they transformed daily life:\nJune 1977, the Apple II From the archives: Apple Computer's 1980 IPO Apple went public back on December 12, 1980. Here's a look back at KTVU-TV's coverage of the event, along with a look at how Apple II computers were being used in the classroom -- a novelty at the time.\nThe Apple II was an improved version of the Apple I computer kit, and started the boom in personal computer sales, according to the National Museum of American History .\nIt was also the first computer to be widely used in schools across the U.S. For millions of today&apos;s adults, their first experience with a computer of any kind came with a version of the Apple II in their classroom â€“ often playing Oregon Trail, Carmen Sandiego, or Odell Lake.\nJanuary 1984, the Macintosh Computer Apple Macintosh computer in 1984 (Credit: KTTV)\nHeralded by a now-most famous TV commercial , the Macintosh computer lived up to the revolutionary promise made by Apple co-founder Steve Jobs during its 1984 unveiling. Among other things, the Mac ushered in the era of the graphical user interface (known as \"GUI\" in tech parlance) and the mouse.\nIn many ways, it was the first realization of Jobsâ€™ vision to turn computers into \"a bicycle of the mind.\"\nAugust 1998, the iMac From the archives: Reviewing the iMac in 1999 We now know Apple's all-in-one iMac marked an important milestone for the company. But what did people think of the colorful computer back when it debuted? Here's a look at FOX 2 Detroit's hands-on review of the iMac. Originally aired December 20, 1999.\nApple redesigned the desktop computer when it released the iMac. The all-in-one colorful egg stood out in bright contrast to the beige, rectangular PCs that Apple was competing with, and was one of the first products that helped rebrand Apple as a hip alternative for a new generation.\nFrom a technical perspective, it was the first mainstream computer that did not include the traditional floppy disk drive. Instead, it was an early adopter of the USB port.\nOctober 2001, the iPod Although it wasnâ€™t the first of its kind, the iPod changed the way people thought about digital music players just like Jimi Hendrix changed the way people thought about the guitar.\nThe iPod was compact, stylish, and initially capable of storing up to 1,000 songs (the capacity would extend far beyond that of the first model in 2001).\nApple Computer Inc. unveiled a new portable music player, the iPod MP3 music player October 23, 2001 at an event in Cupertino, Calif. (Photo Courtesy of Apple Corp. via Getty Images)\nExpand It then spawned the iTunes store, which provided a legal way to buy and download music at a time of rampant MP3 piracy. The device also signaled Apple might evolve into something more than a computer maker.\nJanuary 2007, the iPhone A customer walks into the new Apple store holding a picture of Tim Cook as she is welcomed by the store staff at the Tun Razak Exchange (TRX) on June 22, 2024, in Kuala Lumpur, Malaysia.(Photo by Annice Lyn/Getty Images)\nItâ€™s difficult to overstate how much the iPhone has changed the world. In technical terms, it introduced the convenience of touchscreens at the time that a physical keyboard was still all the rage on the top-selling smartphone â€“ the BlackBerry â€“ when Jobs first took out what was all-in-one computer, camera and music player out of his pocket in 2007.\nA year later, Apple would open a store that would make it common to think there must be an app for just about anything, render the BlackBerry obsolete and make smartphones indispensable.\nRELATED: Apple reportedly working on foldable and thinner iPhone models\nSeptember 2014, the Apple Watch The Apple Watch created a device that made it possible to wear something akin to a smartphone on your wrist because it included cellular capability.\nIt also offered some of the same apps people use on their smartphones. Apple initially marketed its smartwatch almost like a fashion accessory before pivoting once it realized that its fitness and health-tracking features were the tools that people seemed to find most valuable.\nApple announces new AI features for iPhone, Mac Artificial intelligence expert Phil Siegel joins LiveNOW's Andrew Craft to discuss Apple's new AI features for its products.\nRELATED: Watch: Apple Watch SOS alert leads rescuers to injured skiers after 1,000-foot fall\nSeptember 2016, Airpods The AirPods helped popularize wireless headphones with an Apple chip that provided more reliable and stable connections with devices while making it easy to shift from one gadget to another.\nThe product also served another key purpose for Apple: AirPods quickly muted the initial outrage of the companyâ€™s decision to remove the headphone jack from iPhones in 2016 while creating another lucrative sales channel.\nApple's influence on generations Big picture view:\nApple has a long history of designing products that arenâ€™t the first to be introduced in a particular category but still redefine the market.\nFOX 4&apos;s Steve Noviello has covered consumer products and said Apple has garnered a brand loyalty that none of its competitors have achieved, even though they push similar products.\n\"I use my iPhone or really any phone at this point to make payments,\" he said in an interview with FOX Television Stations. \"I pay my mortgage on it. I book my airline travel. I send pictures, I take pictures, I communicate with people. It monitors my heart health.\n\"I mean, it really is amazing what technology has done,\" he continued.",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "positive",
    "categories": [
      "Science and Technology",
      "Science and Technology",
      "Social Issue"
    ],
    "topics": [
      "Science and Technology->history",
      "Science and Technology->scientific publication",
      "Science and Technology->technology and engineering",
      "Science and Technology->history",
      "Science and Technology->technology and engineering",
      "Social Issue->demographics",
      "Social Issue->social networking",
      "Social Issue->social condition"
    ],
    "ai_allow": true,
    "has_canonical": true,
    "breaking": false,
    "webz_reporter": false,
    "external_links": [
      "https://www.ktvu.com/news/apple-reportedly-creating-foldable-thinner-iphones",
      "https://americanhistory.si.edu/collections/object/nmah_334638",
      "https://www.ktvu.com/news/watch-apple-watch-sos-alert-rescuers-injured-skiers",
      "https://www.livenowfox.com/news/1984-apple-super-bowl-commercial",
      "https://www.ktvu.com/tag/organization/apple",
      "https://ktvu.com/news/apple-reportedly-creating-foldable-thinner-iphones",
      "https://www.americanhistory.si.edu/collections/object/nmah_334638",
      "https://livenowfox.com/news/1984-apple-super-bowl-commercial",
      "https://ktvu.com/tag/organization/apple",
      "https://ktvu.com/news/watch-apple-watch-sos-alert-rescuers-injured-skiers"
    ],
    "external_images": [],
    "entities": {
      "persons": [],
      "organizations": [],
      "locations": []
    },
    "syndication": {
      "syndicated": false,
      "syndicate_id": null,
      "first_syndicated": false
    },
    "trust": null,
    "rating": null,
    "crawled": "2025-02-28T00:22:19.227+02:00",
    "updated": "2025-02-28T00:22:19.227+02:00"
  },
  {
    "uuid": "53f632076d411ddd7fa4b6b4562a86da0afd9439",
    "url": "https://www.elperiodico.cat/ca/societat/20250215/papa-francesc-ingressa-l-hospital-114324983",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "Irene Savio",
    "published": "2025-02-14T23:43:00Z",
    "title": "El papa Francesc ingressa a l'hospital per una bronquitis",
    "text": "ReligiÃ³\nEl papa Francesc ingressa a lâ€™hospital per una bronquitis\nEl PontÃ­fex Ã©s a lâ€™Agostino Gemelli de Roma per sotmetreâ€™s a uns quants exÃ mens especialitzats i comenÃ§ar el tractament.\nâ€˜La Repubblicaâ€™ va publicar que sâ€™estarÃ  al centre sanitari durant cinc dies\nEl Papa va ser ingressat ahir a lâ€™hospital Gemelli de Roma. Dâ€™acord amb lâ€™oficina de premsa del VaticÃ , el motiu de lâ€™hospitalitzaciÃ³ del PontÃ­fex Ã©s una \"infecciÃ³ en les vies respiratÃ²ries\" a causa dâ€™una bronquitis i una \"lleu febre\". Francesc \"sâ€™ha sotmÃ¨s a exÃ mens especialitzats i ha comenÃ§at una terÃ pia farmacolÃ²gica hospitalÃ ria\".\nEl VaticÃ  no va informar sobre quant temps es mantindrÃ  ingressat a la desena planta de lâ€™hospital romÃ , on se sol allotjar. De moment, la Santa Seu nomÃ©s ha explicat que sâ€™ha suspÃ¨s la seva presÃ¨ncia en tres actes fins dilluns, quan tenia prevista una trobada amb artistes que finalment ha sigut cancelÂ·lada.\nAixÃ­ mateix, sâ€™ha anulÂ·lat lâ€™audiÃ¨ncia jubilar dâ€™avui i una missa programada per demÃ  diumenge â€“en la qual havia de ser presentâ€“, que presidirÃ  el cardenal JosÃ© Tolentino de MendonÃ§a, prefecte (ministre) del Dicasteri per a la Cultura i lâ€™EducaciÃ³. Tot i aixÃ­, el Papa estÃ  \"tranquil i animat\" i va llegir \"uns quants diaris\", segons va comunicar el portaveu Matteo Bruni.\nUna conseqÃ¼Ã¨ncia immediata dâ€™aquest nou sotrac del Papa ha sigut tambÃ© que lâ€™oficina de premsa vaticana anunciÃ©s que les seves oficines es mantindrien obertes, de manera excepcional, durant tot ahir a la tarda. Una cosa que tambÃ© remet a la gran atenciÃ³ mediÃ tica i a les especulacions que la notÃ­cia ha posat en marxa arreu del mÃ³n. El diari italiÃ  La Repubblica, per exemple, va publicar que fonts prÃ²ximes al Papa parlen dâ€™un ingrÃ©s de cinc dies.\n\"He vist el Papa mentalment alerta perÃ² que tenia moltes dificultats per parlar a causa dels problemes respiratoris\", va dir, per la seva banda, Christopher Lamb, corresponsal de la CNN al VaticÃ , desprÃ©s dâ€™assistir al matÃ­ a una audiÃ¨ncia que Francesc va mantenir amb Mark Thompson, president dâ€™aquesta cadena. Lamb va confirmar dâ€™aquesta manera el que molts vaticanistes han estat assenyalant durant els Ãºltims dies: lâ€™aspecte cansat del Papa i la cara inflada, probablement a causa de la cortisona que li han administrat per combatre la infecciÃ³ respiratÃ²ria.\nUna grip forta\nNotÃ­cies relacionadesDe fet, lâ€™estat de salut de Francesc, de 88 anys i que arrossega diverses patologies, ha tornat a causar preocupaciÃ³ durant els Ãºltims 10 dies. Els primers rumors sobre la nova indisposiciÃ³ que ha tingut el Papa ja van sorgir la setmana passada, quan el PontÃ­fex va comenÃ§ar a manifestar en pÃºblic els primers sÃ­mptomes dâ€™una grip forta. Tot i aixÃ­, diumenge passat, va voler presidir una missa a la plaÃ§a de Sant Pere, en ocasiÃ³ del jubileu de les Forces Armades, durant la qual finalment ell mateix va confessar que tenia \"dificultats a lâ€™hora de respirar\".\nPosteriorment, dimecres, el Papa va demanar en lâ€™Ãºltim moment que un sacerdot llegÃ­s en lloc seu el discurs durant el tradicional Ã ngelus que es porta a terme aquell dia. \"Deixin-me demanar al pare que continuÃ¯ llegint perquÃ¨ encara no puc amb la bronquitis que arrossego. Espero que la prÃ²xima vegada pugui fer-ho\", es va justificar llavors.",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "catalan",
    "sentiment": "negative",
    "categories": [
      "Health",
      "Religion and Belief"
    ],
    "topics": [
      "Health->health treatment and procedure",
      "Health->hospital",
      "Health->medical condition",
      "Religion and Belief->pope",
      "Religion and Belief->christianity",
      "Religion and Belief->religious leader"
    ],
    "ai_allow": true,
    "has_canonical": false,
    "breaking": false,
    "webz_reporter": false,
    "external_links": [],
    "external_images": [],
    "entities": {
      "persons": [],
      "organizations": [],
      "locations": []
    },
    "syndication": {
      "syndicated": null,
      "syndicate_id": null,
      "first_syndicated": false
    },
    "trust": null,
    "rating": null,
    "crawled": "2025-02-15T03:25:14.057+02:00",
    "updated": "2025-02-15T03:25:14.057+02:00"
  },
  {
    "uuid": "ce244d80d9bc8c48520f7d9355ede81eca232fbc",
    "url": "https://crickettimes.com/2025/01/watch-donovan-ferreira-takes-a-superman-esque-catch-to-dismiss-senuran-muthusamy-in-the-sa20-2025",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "Amar Pal Singh Bhalla",
    "published": "2025-01-16T13:37:00Z",
    "title": "WATCH: Donovan Ferreira takes a 'Superman-Esque' catch to dismiss Senuran Muthusamy in the SA20 2025",
    "text": "In an exciting moment during Match 10 of the SA20 2025 tournament between Joburg Super Kings and Pretoria Capitals, Donovan Ferreira delivered a fielding masterclass with a breathtaking â€œSuperman-esqueâ€ catch.\nDonovan Ferreiraâ€™s stunning catch in SA20 2025\nWith Pretoria reeling at 131/8 in the 20th over, Senuran Muthusamy looked to counterattack by launching a length delivery from Hardus Viljoen straight down the ground. The shot seemed destined to clear the fielder, with just enough height and power to evade any attempt. However, Donovan Ferreira had other plans. In a moment of sheer brilliance, Ferreira anticipated the trajectory, turned sharply, and executed an extraordinary leap, extending his hand mid-air to snatch the ball with precision. This exceptional display of athleticism not only dismissed Muthusamy for 8 but also highlighted the pivotal role of sharp fielding in T20 cricket. Ferreiraâ€™s moment of brilliance left fans and commentators in awe, emphasizing the impact of game-changing efforts in tight contests.\nHereâ€™s the video:\nJoburg Super Kings +Spectacular One-handed catches = same whatsapp group ðŸ¤ž\n[#BetwaySA20][#JSKvPC][#WelcomeToIncredible][pic.twitter.com/oVZ9TFYxEH]â€” Betway SA20 (@SA20_League)\n[January 16, 2025]\nAlso WATCH: Dinesh Karthikâ€™s innings cut short by a bizarre run-out in SA20 2025\nRain-interrupted as Pretoria Capitals post 138/8 against Joburg Super Kings\nThe 10th match at The Wanderers Stadium, Johannesburg, saw an eventful first innings After opting to bat, Capitals faced early setbacks with Rahmanullah Gurbaz dismissed for a duck and Will Jacks falling for 15, reducing them to 48/2 within six overs. Kyle Verreynne anchored the innings with a well-crafted 39 off 31 balls, but his dismissal just before the halfway mark triggered a middle-order collapse.\nRilee Rossouw, Liam Livingstone and Marques Ackerman struggled against disciplined bowling led by Moeen Ali, who claimed 2/21 in his four overs. Ferreiraâ€™s all-round brilliance shone through as he dismissed Gurbaz and Neesham, while also taking a spectacular catch to remove Muthusamy in the penultimate over. James Neeshamâ€™s quickfire 30 off 21 provided a late surge, helping the Capitals reach a modest total of 138/8. The Super Kingsâ€™ bowlers, including Imran Tahir (1/17) and Evan Jones (1/3), exploited the conditions effectively, keeping the scoring rate in check throughout. As rain continues to hover, the Super Kings will eye a controlled chase to secure their campaign momentum.",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "positive",
    "categories": [
      "Sport"
    ],
    "topics": [
      "Sport->sport event",
      "Sport->cricket",
      "Sport->regular competition"
    ],
    "ai_allow": true,
    "has_canonical": false,
    "breaking": null,
    "webz_reporter": false,
    "external_links": [],
    "external_images": [],
    "entities": {
      "persons": [],
      "organizations": [],
      "locations": []
    },
    "syndication": {
      "syndicated": false,
      "syndicate_id": "ce244d80d9bc8c48520f7d9355ede81eca232fbc",
      "first_syndicated": true
    },
    "rating": null,
    "crawled": "2025-01-17T00:06:18.618+02:00",
    "updated": "2025-01-17T00:06:18.618+02:00"
  },
  {
    "uuid": "abb84f9983380f2baace30b346cb5951a8aeff45",
    "url": "https://www.semana.com/salud/articulo/el-motivo-por-el-que-no-deberia-usar-tanto-ambientador-en-su-casa/202455",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "RedacciÃ³n Salud",
    "published": "2024-08-29T21:34:00Z",
    "title": "El motivo por el que no deberÃ­a usar tanto ambientador en su casa",
    "text": "El uso excesivo de ambientadores en el hogar puede acarrear serias repercusiones para la salud, segÃºn advierte la AdministraciÃ³n de Alimentos y Medicamentos (FDA, por sus siglas en inglÃ©s). Estos productos, que a menudo se utilizan para mejorar el olor del ambiente, contienen compuestos quÃ­micos que pueden afectar negativamente la salud respiratoria y general de los habitantes.De acuerdo con la FDA, muchos ambientadores contienen ftalatos, que son sustancias quÃ­micas utilizadas para prolongar la fragancia de los productos. Estos ftalatos han sido asociados con problemas endocrinos y reproductivos, y su exposiciÃ³n prolongada puede contribuir a condiciones como el asma y otras enfermedades respiratorias. La Agencia de ProtecciÃ³n Ambiental (EPA) tambiÃ©n ha seÃ±alado que los ambientadores pueden liberar compuestos orgÃ¡nicos volÃ¡tiles (COV), que al ser inhalados pueden irritar los ojos, la piel y las vÃ­as respiratorias.SegÃºn el Instituto Nacional de Seguridad y Salud Ocupacional (NIOSH) de los Estados Unidos, los sÃ­ntomas mÃ¡s comunes de la exposiciÃ³n a estos compuestos incluyen dolores de cabeza, nÃ¡useas y dificultad para respirar. La NIOSH sugiere que el uso excesivo de ambientadores puede aumentar el riesgo de desarrollar enfermedades respiratorias crÃ³nicas, especialmente en personas con condiciones preexistentes como el asma.La OrganizaciÃ³n Mundial de la Salud (OMS) tambiÃ©n ha expresado preocupaciones sobre los efectos de los productos de fragancia en la salud pÃºblica. En un informe reciente, la OMS destacÃ³ que la exposiciÃ³n continua a los quÃ­micos presentes en los ambientadores puede tener efectos adversos en el bienestar general, particularmente en niÃ±os y personas con sistemas inmunitarios comprometidos.Para minimizar los riesgos asociados con el uso de ambientadores, los expertos sugieren adoptar varias estrategias preventivas. En primer lugar, se recomienda reducir la frecuencia y cantidad de ambientadores utilizados en el hogar. Esto puede incluir la limitaciÃ³n de los productos con fragancia y la bÃºsqueda de alternativas mÃ¡s naturales que no comprometan la calidad del aire interior. Una de las opciones mÃ¡s efectivas es mejorar la ventilaciÃ³n de los espacios mediante la apertura de ventanas y el uso de ventiladores , lo cual ayuda a diluir y eliminar los contaminantes presentes en el aire.Otra medida importante es optar por productos sin fragancia y evitar aquellos que contengan quÃ­micos potencialmente daÃ±inos. Al elegir productos para el hogar, es crucial leer cuidadosamente las etiquetas para verificar la ausencia de estos y otros aditivos nocivos. En su lugar, los consumidores pueden considerar el uso de soluciones mÃ¡s seguras y ecolÃ³gicas, como aceites esenciales naturales o mezclas de vinagre y bicarbonato de sodio, que ofrecen opciones menos invasivas para mantener un ambiente fresco sin los riesgos asociados con los productos tradicionales de fragancia.",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "spanish",
    "sentiment": "negative",
    "categories": [
      "Health",
      "Lifestyle and Leisure"
    ],
    "ai_allow": true,
    "webz_reporter": false,
    "external_links": [],
    "external_images": [],
    "entities": {
      "persons": [],
      "organizations": [],
      "locations": []
    },
    "syndication": null,
    "rating": null,
    "crawled": "2024-08-30T03:07:01.529+03:00",
    "updated": "2024-08-30T03:07:01.529+03:00"
  },
  {
    "uuid": "743a8eb0d876e6552fcfaf4f014eb1266390358a",
    "url": "https://www.necn.com/news/national-international/trump-ally-steve-bannon-must-surrender-to-prison-by-july-1-contempt-sentence/3253208",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "@NECN",
    "published": "2024-06-06T19:37:00Z",
    "title": "Trump ally Steve Bannon must surrender to prison by July 1 to start contempt sentence, judge says",
    "text": "Steve Bannon, a longtime ally of former President Donald Trump , must report to prison by July 1 to serve his four-month sentence for defying a subpoena from the House committee that investigated the U.S. Capitol insurrection , a federal judge ruled Thursday.\nU.S. District Judge Carl Nichols in Washington granted the Justice Departmentâ€™s request to make Bannon begin his prison term after a federal appeals court panel last month upheld his contempt of Congress conviction.\nBannon is expected to seek a stay of the judgeâ€™s order, which could delay his surrender date.\nâ€œIâ€™ve got great lawyers, and weâ€™re going to go all the way to the Supreme Court if we have to,â€ Bannon told reporters outside the courthouse. He added: â€œThereâ€™s not a prison built or jail built that will ever shut me up.â€\nIn a social media post Thursday, Trump accused prosecutors of being â€œdesperateâ€ to jail Bannon. Trump repeated his claim that Republicans are being persecuted by a politically motivated justice system â€” rhetoric that has escalated in the wake of the presumptive Republican presidential nomineeâ€™s conviction last week on 34 felony charges in his New York hush money trial.\nNichols, the judge who ordered Bannon to report to prison, was nominated to the bench by Trump in 2018.\nBannon was convicted nearly two years ago of two counts of contempt of Congress: one for refusing to sit for a deposition with the Jan. 6 House Committee and the other for refusing to provide documents related to his involvement in Trumpâ€™s efforts to overturn his 2020 presidential election loss to Democrat Joe Biden.\nNichols had initially allowed him to remain free while he fought his conviction because the judge believed the case raised substantial legal questions. But during a hearing in Washingtonâ€™s federal court, Nichols said the calculus changed after the appeals court panel said all of Bannonâ€™s challenges lack merit.\nâ€œI do not believe the original basis for my stay exists any longer,â€ Nichols said.\nBannon can appeal his conviction to the full U.S. Court of Appeals for the D.C. Circuit and the U.S. Supreme Court. Prosecutor John Crabb told the judge it was â€œvery unlikelyâ€ Bannon would succeed in getting his conviction thrown out.\nBannonâ€™s lawyer at trial argued that the former adviser didnâ€™t ignore the subpoena but was still engaged in good-faith negotiations with the congressional committee when he was charged.\nThe defense has said Bannon had been acting on the advice of his attorney at the time, who told him that the subpoena was invalid because the committee would not allow a Trump lawyer in the room and that Bannon could not determine what documents or testimony he could provide because Trump has asserted executive privilege.\nDefense lawyer David Schoen told the judge it would be unfair to send Bannon to prison now because he would complete his entire sentence before he exhausted his appeals. Schoen said the case raises â€œserious constitutional issuesâ€ that need to be examined by the Supreme Court.\nCapitol Riot Jun 5 Jan. 6 rioter caught in a woman's Bumble dating app sting sentenced to prison news Jun 5 Trump Georgia election case halted pending outcome of challenge to D.A. â€œIn this country, we donâ€™t send anyone to prison if they believe that they were doing something that complied with the law,â€ he told reporters.\nA second Trump aide, trade adviser Peter Navarro, was also convicted of contempt of Congress. He reported to prison in March to serve his four-month sentence .\nNavarro, too, had maintained that he couldnâ€™t cooperate with the committee because Trump had invoked executive privilege. But courts have rejected that argument, finding Navarro couldnâ€™t prove Trump had actually invoked it.\nThe House Jan. 6 committeeâ€™s final report asserted that Trump criminally engaged in a â€œmulti-part conspiracyâ€ to overturn the lawful results of the 2020 election and failed to act to stop his supporters from attacking the Capitol, concluding an extraordinary 18-month investigation into the former president and the violent insurrection.\nBannon is also facing criminal charges in New York state court alleging he duped donors who gave money to build a wall along the U.S. southern border. Bannon has pleaded not guilty to money laundering, conspiracy, fraud and other charges, and that trial has been postponed until at least the end of September.",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "negative",
    "categories": [
      "Politics",
      "Crime, Law and Justice"
    ],
    "webz_reporter": false,
    "external_links": [
      "https://apnews.com/article/peter-navarro-jan-6-prison-congress-contempt-ea6f0e60dda1a7bcaef31012cd2c7678",
      "https://apnews.com/article/trump-trial-deliberations-jury-testimony-verdict-85558c6d08efb434d05b694364470aa0",
      "https://apnews.com/article/jan-6-committee-final-report-trump-bcfea6162fe9cfa0d120e86d069af0e4",
      "https://www.apnews.com/article/jan-6-committee-final-report-trump-bcfea6162fe9cfa0d120e86d069af0e4",
      "https://www.apnews.com/article/trump-trial-deliberations-jury-testimony-verdict-85558c6d08efb434d05b694364470aa0",
      "https://www.apnews.com/article/peter-navarro-jan-6-prison-congress-contempt-ea6f0e60dda1a7bcaef31012cd2c7678"
    ],
    "external_images": [],
    "entities": {
      "persons": [
        {
          "name": "donald trump",
          "sentiment": "negative"
        },
        {
          "name": "steve bannon",
          "sentiment": "negative"
        },
        {
          "name": "bannon",
          "sentiment": "none"
        },
        {
          "name": "carl nichols",
          "sentiment": "none"
        }
      ],
      "organizations": [
        {
          "name": "trump",
          "sentiment": "negative"
        },
        {
          "name": "congress",
          "sentiment": "none"
        },
        {
          "name": "justice department",
          "sentiment": "none"
        },
        {
          "name": "supreme court",
          "sentiment": "none"
        },
        {
          "name": "house",
          "sentiment": "none"
        }
      ],
      "locations": [
        {
          "name": "u.s.",
          "sentiment": "none"
        },
        {
          "name": "u.s. capitol",
          "sentiment": "none"
        },
        {
          "name": "washington",
          "sentiment": "none"
        }
      ]
    },
    "rating": null,
    "crawled": "2024-06-07T00:25:25.304+03:00",
    "updated": "2024-06-07T00:25:25.304+03:00"
  },
  {
    "uuid": "15e4e6613e3914c6e5b5f5140bb735e2491a24a2",
    "url": "https://ici.radio-canada.ca/nouvelle/2123442/negociation-traversier-matane-cote-nord-greve",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "Marguerite Morin",
    "published": "2024-11-29T21:00:00Z",
    "title": "Deux jours de grÃ¨ve en dÃ©cembre Ã  la traverse Matane-CÃ´te-Nord",
    "text": "Deux jours de grÃ¨ve en dÃ©cembre Ã  la traverse Matane-CÃ´te-Nord\nLe F.-A.-Gauthier risque de rester Ã  quai de Matane les 12 et 13 dÃ©cembre en raison d'un conflit de travail. (Photo d'archives)\nPhoto : Radio-Canada / Jean-FranÃ§ois DeschÃªnes\nAprÃ¨s avoir forcÃ© le F.- A. Gauthier Ã  rester Ã  quai durant les vacances de la construction, cet Ã©tÃ©, les deux syndicats des employÃ©s de la traverse Mataneâ€“Baie-Comeauâ€“Godbout menacent de retourner en grÃ¨ve les 12 et 13 dÃ©cembre.\nLe Regroupement des traversiers, syndicat affiliÃ© Ã  la CSN, a signifiÃ© ses intentions au ministÃ¨re du Travail vendredi. Il pige ainsi dans sa banque illimitÃ©e de jours de grÃ¨ve votÃ©e au mois de mai dernier.\nLe syndicat estime que [les nÃ©gociations piÃ©tinent depuis trop longtemps](https://ici.radio-canada.ca/nouvelle/2091822/negociation-traversier-matane-cote-nord-greve) et quâ€™elles achoppent en raison de la position stagnante de la partie patronale, la SociÃ©tÃ© des Traversiers du QuÃ©bec (STQ) et le Conseil du trÃ©sor, et ce, malgrÃ© [les moyens de pression mis en place cet Ã©tÃ©](https://ici.radio-canada.ca/nouvelle/2090046/greve-traverse-matane-cote-nord-syndicat-stq-csn) ainsi que la [nomination dâ€™un conciliateur au dossier](https://ici.radio-canada.ca/nouvelle/2090386/greve-conciliateur-stq-traversier-matane-baie-comeau-godbout).\nLes syndiquÃ©s de la STQ Ã©taient en grÃ¨ve cet Ã©tÃ© durant deux sÃ©quences qui coÃ¯ncidaient avec les vacances de la construction. (Photo d'archives)\nPhoto : Radio-Canada / Claude CÃ´tÃ©\nLe porte-parole du syndicat, Patrick St-Laurent, rappelle Ã©galement que la convention collective est Ã©chue depuis le printemps 2023.\nEn mars 2024, ce nâ€™Ã©tait toujours pas rÃ©glÃ©. On se dirige dangereusement vers mars 2025 [â€¦] on va Ãªtre rendu bientÃ´t Ã  trois augmentations salariales quâ€™on nâ€™a pas eues\n, relÃ¨ve M. St-Laurent.\nCâ€™est une stratÃ©gie dâ€™Ã©tranglement par le temps et on trouve Ã§a un peu indÃ©cent!\nPatrick St-Laurent soutient que, depuis lâ€™arrivÃ©e du conciliateur, les discussions Ã  la table des nÃ©gociations sont bonnes et cordiales. Il constate par contre un rÃ©el blocage au niveau du mandat monÃ©taire imposÃ© par le Conseil du trÃ©sor\n. C'est, selon lui, ce qui motive la prochaine grÃ¨ve.\nLes principaux points Ã  la table de nÃ©gociations sont les salaires et les conditions de travail des employÃ©s. Le syndicat dÃ©plore que les propositions dâ€™augmentations de la partie patronale soient conditionnelles Ã  un consentement de plusieurs reculs du cÃ´tÃ© du syndicat.\nPrÃ©sentement, lâ€™offre de lâ€™employeur câ€™est 12,7 % [dâ€™augmentation sur cinq ans] et si nous acceptons plusieurs reculs inacceptables pour nous, lâ€™offre pourrait monter Ã  17,4 %, ce qui ne permettra mÃªme pas de rehausser les taux horaires Ã  un niveau acceptable face Ã  la concurrence\n, prÃ©cise M. St-Laurent.\nLe porte-parole du Regroupement des traversier CNS, Patrick St-Laurent, dÃ©plore aussi une Â«participation anÃ©miqueÂ» Ã  lâ€™assurance collective de la part de l'employeur. (Photo d'archives)\nPhoto : Radio-Canada / Kevin Duquette-Goulet\nLa STQ indique quâ€™elle ne fera pas de commentaires Ã  ce sujet.\nPar Ã©crit, un reprÃ©sentant de la SociÃ©tÃ© prÃ©cise que le droit de grÃ¨ve de ses travailleurs sera respectÃ©, mais trouve dommage que les employÃ©s aient eu recours Ã  ce moyen de pression Ã  ce moment-ci, puisque les nÃ©gociations se poursuivent, tel que le calendrier des nÃ©gociations le prÃ©voit\n.\nLe Regroupement des traversiers CSN regroupe les deux syndicats de la traverse matanaise et nord-cÃ´tiÃ¨re â€” soit le Syndicat des employÃ©s de la Traverse de Mataneâ€“Baie-Comeauâ€“Godbout et le Syndicat des employÃ©es et employÃ©s de la STQ de Mataneâ€“Baie-Comeauâ€“Godbout â€” ainsi que le Syndicat des employÃ©s de la SociÃ©tÃ© des Traversiers QuÃ©becâ€“LÃ©vis.\nTous sont affiliÃ©s Ã  la FÃ©dÃ©ration des employÃ©es et employÃ©s de services publics (FEESPâ€“CSN).",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "french",
    "sentiment": "negative",
    "categories": [
      "Labor"
    ],
    "ai_allow": true,
    "canonical": false,
    "webz_reporter": false,
    "external_links": [],
    "external_images": [],
    "entities": {
      "persons": [],
      "organizations": [],
      "locations": []
    },
    "syndication": {
      "syndicated": null,
      "syndicate_id": null,
      "first_syndicated": false
    },
    "rating": null,
    "crawled": "2024-11-30T00:17:11.465+02:00",
    "updated": "2024-11-30T00:17:11.465+02:00"
  },
  {
    "uuid": "4714e9cded067f8f56904cf04e15f287684fa9c8",
    "url": "https://news.myseldon.com/en/news/index/332950291",
    "ord_in_thread": 0,
    "author": "@OGirk",
    "published": "2025-07-31T04:37:52Z",
    "title": "ÐÐ¾Ð²ÑƒÑŽ Ð¼ÐµÑ‚Ð¾Ð´Ð¸ÐºÑƒ ÑƒÐ´Ð°Ð»ÐµÐ½Ð¸Ñ Ð³Ñ€Ñ‹Ð¶ Ð¼ÐµÐ¶Ð¿Ð¾Ð·Ð²Ð¾Ð½ÐºÐ¾Ð²Ñ‹Ñ… Ð´Ð¸ÑÐºÐ¾Ð² ÑƒÑÐ¿ÐµÑˆÐ½Ð¾ Ð¿Ñ€Ð¸Ð¼ÐµÐ½ÑÑŽÑ‚ Ð² Ð˜Ñ€ÐºÑƒÑ‚ÑÐºÐµ | Health | Seldon News",
    "text": "Ð¡Ð²Ñ‹ÑˆÐµ 30 Ð¾Ð¿ÐµÑ€Ð°Ñ†Ð¸Ð¹ Ñ Ð¿Ñ€Ð¸Ð¼ÐµÐ½ÐµÐ½Ð¸ÐµÐ¼ Ð½Ð¾Ð²Ð¾Ð¹ Ð¼ÐµÑ‚Ð¾Ð´Ð¸ÐºÐ¸ â€“ Ð±Ð¸Ð¿Ð¾Ñ€Ñ‚Ð°Ð»ÑŒÐ½Ð¾Ð³Ð¾ ÑÐ½Ð´Ð¾ÑÐºÐ¾Ð¿Ð¸Ñ‡ÐµÑÐºÐ¾Ð³Ð¾ ÑƒÐ´Ð°Ð»ÐµÐ½Ð¸Ñ Ð³Ñ€Ñ‹Ð¶ Ð¼ÐµÐ¶Ð¿Ð¾Ð·Ð²Ð¾Ð½ÐºÐ¾Ð²Ñ‹Ñ… Ð´Ð¸ÑÐºÐ¾Ð² (Ð±Ð¸Ð¿Ð¾Ñ€Ñ‚Ð°Ð»ÑŒÐ½Ð°Ñ ÑÐ½Ð´Ð¾ÑÐºÐ¾Ð¿Ð¸Ñ‡ÐµÑÐºÐ°Ñ Ð´Ð¸ÑÐºÑÐºÑ‚Ð¾Ð¼Ð¸Ñ) â€“ Ð²Ñ‹Ð¿Ð¾Ð»Ð½Ð¸Ð»Ð¸ Ð½ÐµÐ¹Ñ€Ð¾Ñ…Ð¸Ñ€ÑƒÑ€Ð³Ð¸ Ð˜Ñ€ÐºÑƒÑ‚ÑÐºÐ¾Ð¹ Ð¾Ð±Ð»Ð°ÑÑ‚Ð½Ð¾Ð¹ ÐºÐ»Ð¸Ð½Ð¸Ñ‡ÐµÑÐºÐ¾Ð¹ Ð±Ð¾Ð»ÑŒÐ½Ð¸Ñ†Ñ‹ (Ð˜ÐžÐšÐ‘). Ð¢ÐµÑ…Ð½Ð¾Ð»Ð¾Ð³Ð¸ÑŽ Ð¾ÑÐ²Ð¾Ð¸Ð»Ð¸ Ð² 2024 Ð³Ð¾Ð´Ñƒ Ð½Ð° Ð¼Ð°ÑÑ‚ÐµÑ€-ÐºÐ»Ð°ÑÑÐµ Ð²ÐµÐ´ÑƒÑ‰Ð¸Ñ… Ð½ÐµÐ¹Ñ€Ð¾Ñ…Ð¸Ñ€ÑƒÑ€Ð³Ð¾Ð² Ð¸Ð· Ð¡Ð°Ð½ÐºÑ‚-ÐŸÐµÑ‚ÐµÑ€Ð±ÑƒÑ€Ð³Ð°. ÐžÐ± ÑÑ‚Ð¾Ð¼ 30 Ð¸ÑŽÐ»Ñ 2025 Ð³Ð¾Ð´Ð° ÑÐ¾Ð¾Ð±Ñ‰Ð¸Ð»Ð° Ð¿Ñ€ÐµÑÑ-ÑÐ»ÑƒÐ¶Ð±Ð° Ð¿Ñ€Ð°Ð²Ð¸Ñ‚ÐµÐ»ÑŒÑÑ‚Ð²Ð° Ñ€ÐµÐ³Ð¸Ð¾Ð½Ð°. Ð¡ÑƒÑ‚ÑŒ Ð¼ÐµÑ‚Ð¾Ð´Ð° Ð·Ð°ÐºÐ»ÑŽÑ‡Ð°ÐµÑ‚ÑÑ Ð² Ð²Ð¸Ð·ÑƒÐ°Ð»Ð¸Ð·Ð°Ñ†Ð¸Ð¸ Ð¾Ð¿ÐµÑ€Ð°Ñ†Ð¸Ð¾Ð½Ð½Ð¾Ð³Ð¾ Ð¿Ð¾Ð»Ñ Ñ Ð¿Ð¾Ð¼Ð¾Ñ‰ÑŒÑŽ ÑÐ½Ð´Ð¾ÑÐºÐ¾Ð¿Ð° Ð¸ ÑƒÐ´Ð°Ð»ÐµÐ½Ð¸Ð¸ Ð³Ñ€Ñ‹Ð¶Ð¸ Ñ‡ÐµÑ€ÐµÐ· Ð´Ð²Ð° Ð½ÐµÐ±Ð¾Ð»ÑŒÑˆÐ¸Ñ… (Ð¼ÐµÐ½ÐµÐµ 1 ÑÐ¼) Ð¿Ñ€Ð¾ÐºÐ¾Ð»Ð°, Ñ‡Ñ‚Ð¾ Ð¿Ð¾Ð·Ð²Ð¾Ð»ÑÐµÑ‚ Ð¸Ð·Ð±ÐµÐ¶Ð°Ñ‚ÑŒ Ð¾Ð±ÑˆÐ¸Ñ€Ð½Ð¾Ð³Ð¾ Ñ€Ð°ÑÑÐµÑ‡ÐµÐ½Ð¸Ñ Ñ‚ÐºÐ°Ð½ÐµÐ¹ Ð¸ ÑÐ¾ÐºÑ€Ð°Ñ‚Ð¸Ñ‚ÑŒ... Copyright information of photo and video materials was taken from the website Â«ÐžÐ±Ð»Ð°ÑÑ‚Ð½Ð°ÑÂ» , more details in our Terms of Service",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "russian",
    "sentiment": "positive",
    "categories": [
      "Health",
      "Science and Technology"
    ],
    "topics": [
      "Health->health treatment and procedure",
      "Health->surgery",
      "Science and Technology->medical research",
      "Science and Technology->technology and engineering",
      "Science and Technology->biomedical science"
    ],
    "ai_allow": true,
    "has_canonical": false,
    "breaking": false,
    "webz_reporter": false,
    "external_links": [
      "http://ogirk.ru/2025/07/31/novuju-metodiku-udalenija-gryzh-mezhpozvonkovyh-diskov-uspeshno-primenjajut-v-irkutske/",
      "http://ogirk.ru/2025/07/31/novuju-metodiku-udalenija-gryzh-mezhpozvonkovyh-diskov-uspeshno-primenjajut-v-irkutske",
      "http://www.ogirk.ru/2025/07/31/novuju-metodiku-udalenija-gryzh-mezhpozvonkovyh-diskov-uspeshno-primenjajut-v-irkutske/"
    ],
    "external_images": [],
    "internal_images": [],
    "entities": {
      "persons": [],
      "locations": [],
      "organizations": []
    },
    "syndication": {
      "syndicated": null,
      "syndicate_id": null,
      "first_syndicated": false
    },
    "trust": {
      "categories": [],
      "top_news": [],
      "bias": null,
      "source": {
        "type": null,
        "city": null,
        "state": null,
        "country": null,
        "domain_type": null,
        "agency": null,
        "organization_name": null
      }
    },
    "rating": null,
    "crawled": "2025-07-31T07:37:52.751+03:00",
    "updated": "2025-07-31T07:41:10.000+03:00"
  }
]